Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor lesion regression and conversion in situ into autologous tumor vaccines by compositions that result in anti-Gal antibody binding

Tumor lesion regression and conversion in situ into autologous tumor vaccines by compositions that result in anti-Gal antibody binding

US Patent 7820628 · Granted Oct 26, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic compositions and methods of use for treating cancer2024
Compositions and methods for increasing immunogenicity of glycoprotein vaccines2019
Glycolipid containing compositions for use in the treatment of tumors2018
Compositions and methods for increasing immunogenicity of glycoprotein vaccines2017
Compositions and methods for wound healing2015
Compositions and methods for wound healing2014
Compositions and methods for wound healing2013
Compositions and methods for wound healing2011
Soft tissue xenografts2004
Methods and compositions for preventing anti-Gal production in xenograft recipie2003
Compositions and methods for vaccines comprising &agr;-galactosyl epitopes2002
Anterior cruciate ligament xenografts2001